ObjectiveTechnical ex-vivo comparison of commercial nebulizer nozzles used for Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC).MethodsThe performance of four different commercial nebulizer nozzles (Nebulizer; HurriChemTM; MCR-4 TOPOL ...
Daniel Göhler +3 more
doaj +1 more source
First reported clinical implementation of pressurized intraperitoneal aerosol chemotherapy in Japan: Program development and 30-day outcomes in two patients. [PDF]
Takeuchi H +7 more
europepmc +1 more source
International audienceThe advantage of administering chemotherapy intraperitoneally (IP) is supported by preclinical and pharmacokinetic data (Tsuji Y et al, Annal Oncology, 2018, Sugarbaker et al, J Gastrointest Oncol, 2021).
Bardet, Sylvia M. +6 more
core
Current Approaches and Emerging Strategies in the Treatment of Peritoneal Carcinomatosis. [PDF]
Alyasova A +18 more
europepmc +1 more source
The Role of Diagnostic Laparoscopy in Staging and Treatment Planning of Gastric Cancer: A 400-Patient Retrospective Cohort Study. [PDF]
Gunes Capar TK +4 more
europepmc +1 more source
Repeated PIPAC in advanced peritoneal metastases: technical feasibility in a real-world case series. [PDF]
Caruso E +15 more
europepmc +1 more source
Clinical research on emerging medical technologies in Japan: Implementation, evaluation, and evidence generation. [PDF]
Karako T.
europepmc +1 more source
Pressurized Intraperitoneal Aerosol Chemotherapy for Platinum-Resistant Ovarian Cancer: A Systematic Review and Meta-Analysis of Clinical Outcomes. [PDF]
Brebu D +11 more
europepmc +1 more source
Gastric cancer peritoneal metastases as an immune compartment: immune evasion, systemic immunotherapy and regional treatment strategies. [PDF]
Burke E.
europepmc +1 more source

